{
  "stageProtocols": {
    "acute": {
      "name": "Acute Phase",
      "timeframe": "<12 months",
      "duration": "3-18",
      "durationUnit": "months",
      "successBase": 65,
      "description": "Early inflammatory phase with active tissue response",
      "characteristics": [
        "Active inflammatory process",
        "Tissue still responsive to intervention", 
        "Lower fibrous tissue formation",
        "Better response to antioxidants"
      ],
      "coreComponents": [
        "vitamin-e",
        "omega-3-complex",
        "propolis",
        "bilberry",
        "silymarin",
        "ginkgo",
        "l-citrulline",
        "curcumin-piperine",
        "pentoxifylline",
        "tadalafil"
      ],
      "optionalComponents": ["vitamin-c", "l-carnitine", "coq10", "magnesium-glycinate"],
      "contraindicated": ["sod", "boswellia"],
      "specialConsiderations": [
        "Monitor for spontaneous improvement",
        "Aggressive antioxidant therapy most effective",
        "Consider waiting period vs early intervention"
      ],
      "verification": "https://www.wjgnet.com/2219-2816/full/v3/i1/31.htm"
    },
    "chronic": {
      "name": "Chronic Phase", 
      "timeframe": ">12 months",
      "duration": "12-48",
      "durationUnit": "months",
      "successBase": 75,
      "description": "Established fibrotic process requiring comprehensive intervention",
      "characteristics": [
        "Stable plaque formation",
        "Reduced inflammatory activity",
        "Established fibrous tissue",
        "Requires multimodal approach"
      ],
      "coreComponents": [
        "l-carnitine",
        "coq10",
        "omega-3-complex",
        "propolis", 
        "ginkgo",
        "l-citrulline",
        "curcumin-piperine",
        "bilberry",
        "silymarin",
        "vitamin-e",
        "vitamin-c",
        "vitamin-d3-k2-complex",
        "magnesium-glycinate",
        "vitamin-b-complex",
        "sod",
        "boswellia", 
        "pentoxifylline",
        "diclofenac",
        "tadalafil"
      ],
      "optionalComponents": ["olive-oil", "copper"],
      "contraindicated": [],
      "specialConsiderations": [
        "Full 12-component protocol recommended",
        "Consider ultrasound enhancement therapy",
        "Long-term treatment commitment required",
        "Injectable therapy mandatory: biweekly for 6 months, then monthly for 12 months"
      ],
      "verification": "https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-022-03614-1"
    },
    "calcified": {
      "name": "Calcified Plaque",
      "timeframe": "Variable",
      "duration": "12-24",
      "durationUnit": "months",
      "successBase": 91,
      "description": "Calcified plaques with pentoxifylline-focused protocol",
      "characteristics": [
        "Calcified plaque deposits",
        "Reduced tissue elasticity", 
        "Higher resistance to treatment",
        "Excellent response to pentoxifylline"
      ],
      "coreComponents": [
        "pentoxifylline",
        "vitamin-d3-k2-complex",
        "l-carnitine",
        "coq10",
        "propolis",
        "ginkgo", 
        "curcumin-piperine",
        "bilberry",
        "silymarin",
        "vitamin-e",
        "vitamin-c",
        "magnesium-glycinate",
        "vitamin-b-complex",
        "sod",
        "boswellia",
        "diclofenac"
      ],
      "optionalComponents": ["copper"],
      "contraindicated": [],
      "specialConsiderations": [
        "Pentoxifylline is priority component",
        "Consider copper if high-dose zinc is used",
        "Consider intralesional therapy",
        "Ultrasound therapy strongly recommended",
        "Highest documented success rate"
      ],
      "verification": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826933/"
    },
    "severe": {
      "name": "Severe Curvature",
      "timeframe": ">60° curvature", 
      "duration": "18-36",
      "durationUnit": "months",
      "successBase": 100,
      "description": "Severe curvature requiring intensive multimodal approach",
      "characteristics": [
        "Curvature >60 degrees",
        "Significant functional impairment",
        "Complex plaque morphology",
        "May require surgical consideration"
      ],
      "coreComponents": [
        "l-carnitine",
        "coq10",
        "propolis",
        "ginkgo",
        "l-citrulline",
        "curcumin-piperine",
        "bilberry",
        "silymarin", 
        "vitamin-e",
        "vitamin-c",
        "vitamin-d3-k2-complex",
        "magnesium-glycinate",
        "vitamin-b-complex",
        "sod",
        "boswellia",
        "pentoxifylline",
        "diclofenac",
        "tadalafil"
      ],
      "optionalComponents": ["copper"],
      "contraindicated": [],
      "specialConsiderations": [
        "Full protocol mandatory",
        "Monitor zinc-copper balance",
        "Surgical consultation may be needed",
        "Longest treatment duration required",
        "Complete plaque regression documented in case series"
      ],
      "verification": "https://www.mdpi.com/2076-3921/11/9/1661"
    }
  },
  "monitoringSchedule": {
    "baseline": {
      "timepoint": "Week 0",
      "clinical": ["Curvature measurement", "IIEF questionnaire"],
      "laboratory": ["CBC", "CMP", "LFT"],
      "imaging": ["Penile ultrasound"],
      "biomarkers": ["TGF-β1 (optional)"],
      "verification": "https://www.auanet.org/guidelines-and-quality/guidelines/peyronies-disease-guideline"
    },
    "week4": {
      "timepoint": "Week 4", 
      "clinical": ["Tolerability assessment"],
      "laboratory": [],
      "imaging": [],
      "biomarkers": []
    },
    "week8": {
      "timepoint": "Week 8",
      "clinical": ["Curvature measurement"],
      "laboratory": [],
      "imaging": ["Optional ultrasound"],
      "biomarkers": []
    },
    "week12": {
      "timepoint": "Week 12",
      "clinical": ["Full clinical assessment"],
      "laboratory": ["Safety labs"],
      "imaging": ["Penile ultrasound"],
      "biomarkers": ["Optional biomarkers"],
      "verification": "https://tau.amegroups.org/article/view/12563/html"
    },
    "quarterly": {
      "timepoint": "Every 3 months",
      "clinical": ["Complete assessment"],
      "laboratory": ["Safety monitoring"],
      "imaging": ["Penile ultrasound"], 
      "biomarkers": ["MMP/TIMP (optional)"],
      "verification": "https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-022-01569-x"
    }
  }
}